United States: For in vitro diagnostic use – FDA Emergency Use Authorization (EUA).
Europe: CE-IVD marked and intended for in vitro diagnostic use in Europe.
For other regions please see our SARS-CoV-2 RUO Panel
The MassARRAY® SARS-CoV-2 Panel from Agena Bioscience® enables laboratories to meet the demands of the COVID-19 pandemic with a high-throughput and low-cost assay for the detection of the novel coronavirus, SARS-CoV-2.
The MassARRAY SARS-CoV-2 Panel is now available, with:
Senior Director of Strategic Innovation, the Advanced Diagnostic Laboratories, National Jewish Health